IGC Pharma(IGC) - 2020 Q2 - Quarterly Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2019 Maryland (State or other jurisdiction of incorporation or organization) 20-2760393 (I.R.S. Employer Identification No.) 10224 Falls Road, Potomac, Maryland ☐ Transition report under Section 13 or 15(d) of the Exchange Act of 1934 (Address of principal executive offices) Commission file num ...